the president of Pfizer Global Research and Development at the time it launched Exubera, an inhaled insulin product that was approved for marketing in early 2006, stated: “In all likelihood, the Afrezza NDA will be approved by the FDA.” And in noting Exubera’s approval, it should also be noted that there is virtually no disagreement that Afrezza is far superior to Exubera, in terms of efficacy, safety, ease of use, and price.
Doesn't Jay Skyler MD PhD answer all this on the video? There seems to be no safety concerns by him.
There aren't too many people that don't think Afreeza won't be approved. What is your opinion?
You at it again Ajohn, Kingajohn32, opc11? You are really a nut case.